Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
1997 2
2000 4
2003 3
2005 2
2006 1
2007 2
2008 1
2011 1
2013 1
2014 3
2015 2
2016 1
2017 1
2018 3
2019 1
2020 4
2022 2
2023 2
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2416-2425. doi: 10.1016/S0140-6736(24)00549-X. Epub 2024 May 16. Lancet. 2024. PMID: 38763153 Free PMC article. Clinical Trial.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2405-2415. doi: 10.1016/S0140-6736(24)00548-8. Epub 2024 May 16. Lancet. 2024. PMID: 38763154 Free PMC article. Clinical Trial.
Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials.
Smith AW, DiMartino L, Garcia SF, Mitchell SA, Ruddy KJ, Smith JD, Wong SL, Cahue S, Cella D, Jensen RE, Hassett MJ, Hodgdon C, Kroner B, Osarogiagbon RU, Popovic J, Richardson K, Schrag D, Cheville AL; IMPACT Consortium. Smith AW, et al. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad073. doi: 10.1093/jncics/pkad073. JNCI Cancer Spectr. 2023. PMID: 37930033 Free PMC article.
Neonatal immunity: how well has it grown up?
Marshall-Clarke S, Reen D, Tasker L, Hassan J. Marshall-Clarke S, et al. Among authors: tasker l. Immunol Today. 2000 Jan;21(1):35-41. doi: 10.1016/s0167-5699(99)01548-0. Immunol Today. 2000. PMID: 10637557 Review. No abstract available.
Strategies for Implementing an Electronic Patient-Reported Outcomes-Based Symptom Management Program Across Six Cancer Centers.
Hassett MJ, Dias S, Cronin C, Schrag D, McCleary N, Simpson J, Poirier-Shelton T, Bian J, Reich J, Dizon D, Begnoche M, Jenkins HH, Tasker L, Wong S, Pearson L, Paudel R, Osarogiagbon RU. Hassett MJ, et al. Among authors: tasker l. Res Sq [Preprint]. 2024 Jan 24:rs.3.rs-3879836. doi: 10.21203/rs.3.rs-3879836/v1. Res Sq. 2024. Update in: BMC Health Serv Res. 2024 Nov 12;24(1):1386. doi: 10.1186/s12913-024-11536-5 PMID: 38343857 Free PMC article. Updated. Preprint.
Applications of nanotechnology in orthopaedics.
Tasker LH, Sparey-Taylor GJ, Nokes LD. Tasker LH, et al. Clin Orthop Relat Res. 2007 Mar;456:243-9. doi: 10.1097/BLO.0b013e31803125f4. Clin Orthop Relat Res. 2007. PMID: 17224843 Review.
Scoping review of indicators and methods of measurement used to evaluate the impact of dog population management interventions.
Hiby E, Atema KN, Brimley R, Hammond-Seaman A, Jones M, Rowan A, Fogelberg E, Kennedy M, Balaram D, Nel L, Cleaveland S, Hampson K, Townsend S, Lembo T, Rooney N, Whay HR, Pritchard J, Murray J, van Dijk L, Waran N, Bacon H, Knobel D, Tasker L, Baker C, Hiby L. Hiby E, et al. Among authors: tasker l. BMC Vet Res. 2017 May 30;13(1):143. doi: 10.1186/s12917-017-1051-2. BMC Vet Res. 2017. PMID: 28558736 Free PMC article. Review.
Bridging clinical informatics and implementation science to improve cancer symptom management in ambulatory oncology practices: experiences from the IMPACT consortium.
McCleary NJ, Merle JL, Richardson JE, Bass M, Garcia SF, Cheville AL, Mitchell SA, Jensen R, Minteer S, Austin JD, Tesch N, DiMartino L, Hassett MJ, Osarogiagbon RU, Wong S, Schrag D, Cella D, Smith AW, Smith JD; IMPACT Consortium. McCleary NJ, et al. JAMIA Open. 2024 Sep 4;7(3):ooae081. doi: 10.1093/jamiaopen/ooae081. eCollection 2024 Oct. JAMIA Open. 2024. PMID: 39234146 Free PMC article.
42 results